Emergent Biosolutions EBS Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's accumulated depreciation?
- Emergent Biosolutions (EBS) reported accumulated depreciation of $310M in Q1 2026.
- How has Emergent Biosolutions's accumulated depreciation changed year-over-year?
- Emergent Biosolutions's accumulated depreciation increased by 4.4% year-over-year, from $296.8M to $310M.
- What is the long-term trend for Emergent Biosolutions's accumulated depreciation?
- Over 5 years (2020 to 2025), Emergent Biosolutions's accumulated depreciation has grown at a 3.3% compound annual growth rate (CAGR), from $259.1M to $304.1M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.